Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC1A2 antisense RNA 1 (SLC1A2-AS1) is a long non-coding RNA transcript that is derived from the antisense strand of the SLC1A2 locus. Such antisense RNAs may play roles in post-transcriptional gene regulation, often by influencing the expression or stability of their sense partners (in this case, SLC1A2, which encodes a high-affinity glutamate transporter involved in central nervous system glutamate clearance). However, no functional or disease association for SLC1A2-AS1 itself is described in current biomedical resources.
None known or established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC1A2 antisense RNA 1 (SLC1A2-AS1).